Predict your next investment

Founded Year

2000

Stage

Asset Sale | AssetsPurchased

Total Raised

$2.1M

About Eutech

Developer of non-surgical products for the treatment of patients with urinary incontinence. The company's business concept is to develop and provide effective, non-surgical treatment alternatives for patients with severe urinary incontinence and to offer an efficient alternative to indwelling catheters for patients with a need for long term urinary drainage. Based on a common technology platform, both an incontinence valve and a urinary drainage suitable for the female anatomy are being developed.

Eutech Headquarter Location

Medicinaregatan 8B

Gothenburg, 413 90,

Sweden

46 31 82 98 40

Latest Eutech News

Investigational New Drug Approval of Potential COVID-19 Medication by FDA

Aug 31, 2021

) Highland Park, NJ—Global Coronaviruses (Covid-19) deadly infection has urged the world’s pharmaceutical scientists and global health professionals to accelerate the Covid-19 treatment and vaccine development. EuTech Scientific Services, Inc.'s (EuTech) experienced team has worked hand-in-hand with IHP Therapeutics (IHP) to perform a complete characterization of their biological drug IHP-009 to ensure that it meets FDA regulations. The characterization data submitted to the FDA resulted in IND approval of IHP-009 in March of 2021. Characterization of biologics is different than small molecules that has a well-defined structure. Biologics are very large in size, and their structure identifications have to include inherent variability associated with being of biological origin. “Our team is honored to be a trusted lab of choice to perform complete characterization of a biological drug in a timely manner to ensure sensitive worldwide Covid-19 cure development progress,” said Dr. Raghvendra Sahai, President, ARL-EuTech Scientific Services, Inc. About ARL-EuTech Scientific Services Founded in 1994, EuTech partners with Pharmaceutical and Medical device companies in their Drug Development and quality assurance programs strictly adhering to FDA’s GLP/GMP guidelines. It is also DEA licensed Schedule (I-V), and extends services to dietary supplements, nutraceuticals and raw material suppliers. It has helped several pharma companies in detailed analysis of raw materials, API, excipients becoming their formulation development partner. Pharmaceutical companies for the last two decades have utilized EuTech to ensure that their packaging is safe, and all the extractable leachable data meets FDA guidelines, further performing all the required testing for each lot release. In June 2021, EuTech became a member of the Tentamus family of companies, joining hands with ARL to become ARL-EuTech, offering its pharmaceutical clients better and more comprehensive services. Tentamus Group GmbH Tentamus Group GmbH was founded in 2011. Tentamus is a global product and safety group with a core presence in Europe, UK, Israel, China, Japan, India and the USA. Accredited and licensed Tentamus Group tests, audits and consults on all products involving the human body (food & feed, pharmaceuticals & medical, agrosciences, cosmetics, agriculture & environment and nutraceutical & supplements). Tentamus Group is represented in over 80 locations worldwide. More than 3,000 highly-trained staff members work in over 3 million square feet of laboratory and office spaces. For further information please visit www.tentamus.com . Das könnte Sie auch interessieren 26.08.2021

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Eutech Patents

Eutech has filed 1 patent.

The 3 most popular patent topics include:

  • Data management
  • Enterprise application integration
  • Enterprise architecture
patents chart

Application Date

Grant Date

Title

Related Topics

Status

1/6/2020

Enterprise application integration, Production and manufacturing, Enterprise architecture, Java platform, Data management

Application

Application Date

1/6/2020

Grant Date

Title

Related Topics

Enterprise application integration, Production and manufacturing, Enterprise architecture, Java platform, Data management

Status

Application

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.